Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Non-Current Debt: 2023-2024

Historic Non-Current Debt for Zhengye Biotechnology Holding (ZYBT) over the last 2 years, with Dec 2024 value amounting to $658,000.

  • Zhengye Biotechnology Holding's Non-Current Debt was N/A to $649,788 in Q2 2025 from the same period last year, while for Jun 2025 it was $649,788, marking a year-over-year change of. This contributed to the annual value of $658,000 for FY2024, which is 53.45% down from last year.
  • Latest data reveals that Zhengye Biotechnology Holding reported Non-Current Debt of $658,000 as of FY2024, which was down 53.45% from $1.4 million recorded in FY2023.
  • Zhengye Biotechnology Holding's 5-year Non-Current Debt high stood at $1.4 million for FY2023, and its period low was $658,000 during FY2024.